HFNC for Postoperative Atelectasis After Laparoscopic Surgery
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorBursa Yuksek Ihtisas Training and Research Hospital
About this trial
Pneumoperitoneum and Trendelenburg positioning during laparoscopic surgery promote atelectasis development, which has been reported in up to 90% of patients under general anesthesia and increases the risk of postoperative pulmonary complications. High-flow nasal cannula (HFNC) oxygen therapy may reduce post-extubation atelectasis through alveolar recruitment. This prospective observational cohort study aims to evaluate the role of HFNC in postoperative atelectasis monitored by lung ultrasonography (LUS) in patients undergoing elective laparoscopic surgery.
Eligibility criteria
Qualifiers
Adult patients aged 18 years and older
Patients scheduled for elective laparoscopic surgery (general surgery, urology, gynecology)
Patients undergoing mechanical ventilation under general anesthesia
ASA physical status I-III
Disqualifiers
Severe or uncontrolled chronic obstructive pulmonary disease, asthma, or other chronic pulmonary diseases
Patients with atelectasis or pleural effusion detected on preoperative lung ultrasonography
Patients requiring intraoperative recruitment maneuver
ASA physical status IV or above
Trial design
Treatments tested in this trial
- High-Flow Nasal Cannula (HFNC)
- Conventional Oxygen Therapy
Treatment groups
90 Participants
are divided into 2 treatment groupsLocations
Sponsors and collaborators
Source ClinicalTrials.gov